4//SEC Filing
Hadas Nicole R. 4
Accession 0001562180-24-002022
CIK 0001517022other
Filed
Feb 29, 7:00 PM ET
Accepted
Mar 1, 5:48 PM ET
Size
5.0 KB
Accession
0001562180-24-002022
Insider Transaction Report
Form 4
Hadas Nicole R.
VP General Counsel & Secretary
Transactions
- Sale
Common Stock
2024-02-29$1.58/sh−5,974$9,439→ 663,259 total
Footnotes (1)
- [F1]This sale was made automatically by the Issuer to cover tax withholding obligations in connection with the vesting and settlement of one-third of the reporting person's restricted stock units granted on February 28, 2022.
Documents
Issuer
Akebia Therapeutics, Inc.
CIK 0001517022
Entity typeother
Related Parties
1- filerCIK 0001602396
Filing Metadata
- Form type
- 4
- Filed
- Feb 29, 7:00 PM ET
- Accepted
- Mar 1, 5:48 PM ET
- Size
- 5.0 KB